40 studies found for:    Behcet's Disease
Show Display Options
Rank Status Study
21 Terminated Tocilizumab for the Treatment of Behcet's Syndrome
Condition: Behcet's Syndrome.
Intervention: Drug: Tocilizumab
22 Completed A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
Condition: Behcet Syndrome
Interventions: Drug: Apremilast (CC-10004);   Drug: Placebo
23 Recruiting Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)
Condition: Behcet's Uveitis
Interventions: Drug: Gevokizumab;   Drug: Placebo
24 Recruiting A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
Condition: Female Patients With Behcet's Syndrome
Intervention: Drug: Abatacept
25 Terminated Safety and Efficacy of AIN457 in Behçet's Patients With Posterior or Panuveitis
Condition: Uveitis
Interventions: Biological: AIN457;   Drug: Placebo
26 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
27 Recruiting Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Conditions: Other Specified Inflammatory Disorders of Skin or Subcutaneous Tissue;   Pyoderma Gangrenosum;   Erosive Pustular Dermatosis of the Scalp;   Sweet's Syndrome;   Behcet's Disease;   Bowel-associated Dermatosis-arthritis Syndrome;   Pustular Psoriasis;   Acute Generalized Exanthematous Pustulosis;   Keratoderma Blenorrhagicum;   Sneddon-Wilkinson Disease;   IgA Pemphigus;   Amicrobial Pustulosis of the Folds;   Infantile Acropustulosis;   Transient Neonatal Pustulosis;   Neutrophilic Eccrine Hidradenitis;   Rheumatoid Neutrophilic Dermatitis;   Neutrophilic Urticaria;   Still's Disease;   Erythema Marginatum;   Unclassified Periodic Fever Syndromes / Autoinflammatory Syndromes;   Dermatitis Herpetiformis;   Linear IgA Bullous Dermatosis;   Bullous Systemic Lupus Erythematosus;   Inflammatory Epidermolysis Bullosa Aquisita;   Neutrophilic Dermatosis of the Dorsal Hands (Pustular Vasculitis);   Small Vessel Vasculitis Including Urticarial Vasculitis;   Erythema Elevatum Diutinum;   Medium Vessel Vasculitis
Intervention: Procedure: Collection of biological samples
28 Completed Uveitis Gene-Expression Profiling
Condition: Uveitis
Intervention:
29 Recruiting Efficacy of Humira in Behcet Patients With Arthritis
Condition: Arthritis; Behcet
Intervention: Drug: Adalimumab (Humira)
30 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Intervention: Biological: Hematopoietic Stem Cell Transplant
31 Completed Evaluation and Treatment of Patients With Inflammatory Eye Diseases
Conditions: Choroiditis;   Iridocyclitis;   Iritis;   Retinal Disease
Intervention:
32 Recruiting Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
Conditions: Psoriasis;;   Psoriatic Arthritis;;   Psoriasis Arthropatica
Interventions: Drug: Apremilast;   Drug: Placebo
33 Active, not recruiting Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Conditions: Psoriasis;   Psoriatic Arthritis
Interventions: Drug: Apremilast tablet/pill 30 mg;   Drug: Etanercept 50 mg;   Drug: Placebo tablet;   Drug: Placebo injection (saline)
34 Terminated Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels
Conditions: Coronary Artery Disease;   Inflammatory Response;   Atherosclerosis
Intervention: Dietary Supplement: eicosapentaenoic acid (EPA),
35 Completed Biological Markers in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
36 Completed Ilaris (Canakinumab) in the Schnitzler Syndrome
Condition: Schnitzler Syndrome
Intervention: Drug: Ilaris
37 Active, not recruiting Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study
Conditions: Acute Lymphoblastic Leukemia;   Nephrotic Syndrome;   Rheumatism
Intervention:
38 Enrolling by invitation Stem Cell Transplantation for the Treatment of Knee Osteoarthritis
Condition: Knee Osteoarthritis
Intervention: Biological: Autologous Stem Cell Transplantation
39 Recruiting Studies of the Natural History and Pathogenesis and Outcome of Neonatal Onset Multisystem Inflammatory Disease (NOMID/CAPS, DIRA, CRMO, Still s Disease, Behcet s Disease, and Other Undifferentiated Autoinflammatory Diseases)
Conditions: Urticaria;   Arthropathy;   Lymphadenopathy;   Nervous System Anomalies
Intervention:
40 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page
Indicates status has not been verified in more than two years